Digma Medical Overview

  • Founded
  • 2013

Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 6

Digma Medical General Information

Description

Developer of noninvasive medical devices intended to develop effective new therapies for type 2 diabetes. The company's devices restore the body's natural ability to control glucose, potentially providing long-term remission from type 2 diabetes, enabling diabetic patients to improve their quality of life and long-term health outcomes.

Contact Information

Website
www.digmamedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Therapeutic Devices
Primary Office
  • Tel Aviv
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Digma Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 01-Dec-2016 Completed Generating Revenue
3. Early Stage VC 01-Apr-2015 Completed Generating Revenue
2. Seed Round 01-Apr-2013 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Digma Medical’s complete valuation and funding history, request access »

Digma Medical Patents

  • 31

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Digma Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3496800-A1 Apparatus and method for nerve ablation in the wall of the gastointestinal tract Active 14-Aug-2016 000000000
EP-3496800-B1 Apparatus for nerve ablation in the wall of the gastointestinal tract Active 14-Aug-2016 000000000
EP-3811999-A1 Apparatus and method for nerve ablation in the wall of the gastointestinal tract Pending 14-Aug-2016 000000000 0
EP-3496800-A4 Apparatus and method for nerve ablation in the wall of the gastointestinal tract Active 14-Aug-2016 000000000 0
JP-2022095708-A Devices and methods for nerve ablation in the walls of the gastrointestinal tract Pending 14-Aug-2016 A61B18/22
To view Digma Medical’s complete patent history, request access »

Digma Medical Executive Team (8)

Name Title Board Seat Contact Info
Ilan Ben-Oren Co-Founder, Board Member & Chief Technology Officer
Brian Levy MD Chief Medical Officer
Irit Yaniv MD Co-Founder & Board Member
Scott Huennekens Executive Chairman
You’re viewing 4 of 8 executive team members. Get the full list »

Digma Medical Board Members (7)

Name Representing Role Since
Anat Tsour Segal Digma Medical Board Member 000 0000
Eyal Dior Tal Ventures Board Member 000 0000
Irit Yaniv MD Self Co-Founder & Board Member 000 0000
Mori Arkin Accelmed Board Member 000 0000
Scott Huennekens Self Executive Chairman 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Digma Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Digma Medical Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arkin Holdings Venture Capital Minority 000 0000 000000 0
Peregrine Ventures Venture Capital Minority 000 0000 000000 0
Tal Ventures Venture Capital Minority 000 0000 000000 0
Accelmed Ventures Venture Capital Minority 000 0000 000000 0
Israel Innovation Authority Government Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial